{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:31:44Z","timestamp":1790947904136,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11695-025-08036-8","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:26:29Z","timestamp":1752139589000},"page":"3006-3012","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of Prophylactic Apixaban for 14 Days After Sleeve Gastrectomy on Thromboembolic Events and Its Side Effects"],"prefix":"10.1007","volume":"35","author":[{"given":"Graziella","family":"Galvao Goncalves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany","family":"Takla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Jodicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoel","family":"Galvao Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"issue":"2","key":"8036_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.soard.2010.12.008","volume":"7","author":"DA Winegar","year":"2011","unstructured":"Winegar DA, Sherif B, Pate V, DeMaria EJ. Venous thromboembolism after bariatric surgery performed by Bariatric Surgery Center of Excellence Participants: analysis of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2011;7(2):181\u20138. https:\/\/doi.org\/10.1016\/j.soard.2010.12.008.","journal-title":"Surg Obes Relat Dis"},{"issue":"5","key":"8036_CR2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1177\/000313480507100508","volume":"71","author":"BK Poulose","year":"2005","unstructured":"Poulose BK, Griffin MR, Zhu Y, Smalley W, Richards WO, Wright JK, et al. National analysis of adverse patient safety events in bariatric surgery. Am Surg. 2005;71(5):406\u201313. https:\/\/doi.org\/10.1177\/000313480507100508.","journal-title":"Am Surg"},{"issue":"4","key":"8036_CR3","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s11695-024-07100-z","volume":"34","author":"FA Guzman-Pruneda","year":"2024","unstructured":"Guzman-Pruneda FA, Garcia A, Crum RW, Chen T, Krikhely A, Bessler M. Extended post discharge prophylaxis for venous thromboembolism prevention after bariatric surgery. Obes Surg. 2024;34(4):1217\u201323. https:\/\/doi.org\/10.1007\/s11695-024-07100-z.","journal-title":"Obes Surg"},{"issue":"5","key":"8036_CR4","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.soard.2019.02.017","volume":"15","author":"LN Clark","year":"2019","unstructured":"Clark LN, Helm MC, Gould JC. Practice patterns regarding post-discharge chemoprophylaxis for venous thromboembolism following bariatric surgery in the United States. Surg Obes Relat Dis. 2019;15(5):703\u20137. https:\/\/doi.org\/10.1016\/j.soard.2019.02.017.","journal-title":"Surg Obes Relat Dis"},{"issue":"11","key":"8036_CR5","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1007\/s00464-008-0031-9","volume":"22","author":"I Raftopoulos","year":"2008","unstructured":"Raftopoulos I, Martindale C, Cronin A, Steinberg J. The effect of extended post-discharge chemical thromboprophylaxis on venous thromboembolism rates after bariatric surgery: a prospective comparison trial. Surg Endosc. 2008;22(11):2384\u201391. https:\/\/doi.org\/10.1007\/s00464-008-0031-9.","journal-title":"Surg Endosc"},{"issue":"1","key":"8036_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/SLA.0000000000001686","volume":"265","author":"A Aminian","year":"2017","unstructured":"Aminian A, Andalib A, Khorgami Z, Cetin D, Burguera B, Bartholomew J, et al. Who should get extended thromboprophylaxis after bariatric surgery?: a risk assessment tool to guide indications for post-discharge pharmacoprophylaxis. Ann Surg. 2017;265(1):143\u201350. https:\/\/doi.org\/10.1097\/SLA.0000000000001686.","journal-title":"Ann Surg"},{"issue":"2","key":"8036_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.soard.2019.10.025","volume":"16","author":"JI Mechanick","year":"2020","unstructured":"Mechanick JI, Apovian C, Brethauer S, Garvey WT, Joffe AM, Kim J, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists\/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Surg Obes Relat Dis. 2020;16(2):175\u2013247. https:\/\/doi.org\/10.1016\/j.soard.2019.10.025.","journal-title":"Surg Obes Relat Dis"},{"key":"8036_CR8","doi-asserted-by":"publisher","unstructured":"Aminian A, Vosburg RW, Altieri MS, Hinojosa MW, Khorgami Z, American Society for M, et al. The American Society for Metabolic and Bariatric Surgery (ASMBS) updated position statement on perioperative venous thromboembolism prophylaxis in bariatric surgery. Surg Obes Relat Dis. 2022;18(2):165\u201374. https:\/\/doi.org\/10.1016\/j.soard.2021.10.023.","DOI":"10.1016\/j.soard.2021.10.023"},{"issue":"8","key":"8036_CR9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.soard.2022.12.038","volume":"19","author":"S Giannopoulos","year":"2023","unstructured":"Giannopoulos S, Kalantar Motamedi SM, Athanasiadis DI, Clapp B, Lyo V, Ghanem O, et al. Venous thromboembolism (VTE) prophylaxis after bariatric surgery: a national survey of MBSAQIP director practices. Surg Obes Relat Dis. 2023;19(8):799\u2013807. https:\/\/doi.org\/10.1016\/j.soard.2022.12.038.","journal-title":"Surg Obes Relat Dis"},{"issue":"9717","key":"8036_CR10","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S0140-6736(09)62125-5","volume":"375","author":"MR Lassen","year":"2010","unstructured":"Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Hornick P, et al. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. Lancet. 2010;375(9717):807\u201315. https:\/\/doi.org\/10.1016\/S0140-6736(09)62125-5.","journal-title":"Lancet"},{"key":"8036_CR11","unstructured":"Bristol-Myers Squibb Company, Pfizer Inc. Eliquis (apixaban) tablets, for oral use: prescribing information. U.S. Food and Drug Administration; 2021. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/202155s032lbl.pdf. Accessed 12\/1\/2024."},{"issue":"3","key":"8036_CR12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11239-021-02573-6","volume":"53","author":"D DeCamillo","year":"2022","unstructured":"DeCamillo D, Haymart B, Barnes GD. Adverse events in patients taking apixaban or rivaroxaban who have undergone bariatric surgery: a retrospective case series. J Thromb Thrombolysis. 2022;53(3):601\u20136. https:\/\/doi.org\/10.1007\/s11239-021-02573-6.","journal-title":"J Thromb Thrombolysis"},{"issue":"12","key":"8036_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-236202","volume":"13","author":"O Jaikaran","year":"2020","unstructured":"Jaikaran O, Lim D, Binetti B, Meytes V. Portomesenteric thrombosis after robotic sleeve gastrectomy. BMJ Case Rep. 2020;13(12): e236202. https:\/\/doi.org\/10.1136\/bcr-2020-236202.","journal-title":"BMJ Case Rep"},{"issue":"2","key":"8036_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.15386\/mpr-1372","volume":"93","author":"C Hotoleanu","year":"2020","unstructured":"Hotoleanu C. Association between obesity and venous thromboembolism. Med Pharm Rep. 2020;93(2):162\u20138. https:\/\/doi.org\/10.15386\/mpr-1372.","journal-title":"Med Pharm Rep"},{"issue":"8","key":"8036_CR15","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1111\/jth.13369","volume":"14","author":"LD Horvei","year":"2016","unstructured":"Horvei LD, Grimnes G, Hindberg K, Mathiesen EB, Njolstad I, Wilsgaard T, et al. C-reactive protein, obesity, and the risk of arterial and venous thrombosis. J Thromb Haemost. 2016;14(8):1561\u201371. https:\/\/doi.org\/10.1111\/jth.13369.","journal-title":"J Thromb Haemost"},{"key":"8036_CR16","doi-asserted-by":"publisher","unstructured":"Allman-Farinelli MA. Obesity and venous thrombosis: a review. Semin Thromb Hemost.\u00a02011;37(8):903\u20137. https:\/\/doi.org\/10.1055\/s-0031-1297369. Available from: https:\/\/www.thieme-connect.de\/products\/ejournals\/abstract\/10.1055\/s-0031-1297369.","DOI":"10.1055\/s-0031-1297369"},{"issue":"9","key":"8036_CR17","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s11695-011-0445-7","volume":"21","author":"KE Steele","year":"2011","unstructured":"Steele KE, Schweitzer MA, Prokopowicz G, Shore AD, Eaton LC, Lidor AO, et al. The long-term risk of venous thromboembolism following bariatric surgery. Obes Surg. 2011;21(9):1371\u20136. https:\/\/doi.org\/10.1007\/s11695-011-0445-7.","journal-title":"Obes Surg"},{"issue":"7","key":"8036_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11695-022-06051-7","volume":"32","author":"A Surve","year":"2022","unstructured":"Surve A, Potts J, Cottam D, Roslin M, Medlin W, Uchal M, et al. The safety and efficacy of apixaban (Eliquis) in 5017 post-bariatric patients with 95.3% follow-up: a multicenter study. Obes Surg. 2022;32(7):1\u20136. https:\/\/doi.org\/10.1007\/s11695-022-06051-7.","journal-title":"Obes Surg."},{"issue":"4","key":"8036_CR19","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.soard.2017.10.013","volume":"14","author":"RC Moon","year":"2018","unstructured":"Moon RC, Ghanem M, Teixeira AF, De La Cruz-Munoz N, Young MK, Domkowski P, et al. Assessing risk factors, presentation, and management of portomesenteric vein thrombosis after sleeve gastrectomy: a multicenter case-control study. Surg Obes Relat Dis. 2018;14(4):478\u201383. https:\/\/doi.org\/10.1016\/j.soard.2017.10.013.","journal-title":"Surg Obes Relat Dis"},{"issue":"3","key":"8036_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11239-016-1465-x","volume":"43","author":"HA Hakeam","year":"2017","unstructured":"Hakeam HA, Al-Sanea N. Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs). J Thromb Thrombolysis. 2017;43(3):343\u201351. https:\/\/doi.org\/10.1007\/s11239-016-1465-x.","journal-title":"J Thromb Thrombolysis"},{"key":"8036_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.thromres.2017.11.006","volume":"163","author":"A Rottenstreich","year":"2018","unstructured":"Rottenstreich A, Barkai A, Arad A, Raccah BH, Kalish Y. The effect of bariatric surgery on direct-acting oral anticoagulant drug levels. Thromb Res. 2018;163:190\u20135. https:\/\/doi.org\/10.1016\/j.thromres.2017.11.006.","journal-title":"Thromb Res"},{"issue":"6","key":"8036_CR22","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1310\/hpj4806-494","volume":"48","author":"DJ Cada","year":"2013","unstructured":"Cada DJ, Levien TL, Baker DE. Apixaban. Hosp Pharm. 2013;48(6):494\u2013509. https:\/\/doi.org\/10.1310\/hpj4806-494.","journal-title":"Hosp Pharm"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-025-08036-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-025-08036-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-025-08036-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T02:03:30Z","timestamp":1756260210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-025-08036-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["8036"],"URL":"https:\/\/doi.org\/10.1007\/s11695-025-08036-8","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board approval was obtained for this study.For this type of study, formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Andre Teixeira serves as a consultant for Intuitive. Manoel Galvao Neto serves as a consultant for Boston Scientific, GI Windows, Morphic, Intuitive, Arthrex, and Olympus. These relationships do not influence the presented research findings.  All other authors have no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}